July 2022 - Kidney Cancer UK

New Approach to Treating VHL RCC

The research could be used to develop more targeted kidney cancer drugs. Researchers from Sweden’s Karolinska ...

Savolitinib, alone or in combination with durvalumab, did not demonstrate significant efficacy in patients with ...

Adding cabozantinib (Cabometyx) to nivolumab (Opdivo) and ipilimumab (Yervoy) improved progression-free survival ...

Statins are widely used in an ageing population, including subjects with solid malignancies. However, no ...